Rare Lichen Planus

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

IFNG, TNF, IL6, BCL2, FOXP3, DSG1, ERVW-1, IL23A, JAK1, HLA-DRB1, CXCR3, CXCL9, FLG, DSG3, IL17A, PTGS2, VCAM1, VIM, ABCC8, YME1L1, ZEB1, TGFB1, GNLY, ABCB6, TGM2, TLR4, APOBEC3B, AIM2, NRP2, TP63

IFNG, TNF, IL6, BCL2, FOXP3, DSG1, ERVW-1, IL23A, JAK1, HLA-DRB1, CXCR3, CXCL9, FLG, DSG3, IL17A, PTGS2, VCAM1, VIM, ABCC8, YME1L1, ZEB1, TGFB1, GNLY, ABCB6, TGM2, TLR4, APOBEC3B, AIM2, NRP2, TP63, TP53, TWIST1, UVRAG, CKAP4, WNT5A, ADM, VASH1, MIR155HG, LINC02210-CRHR1, MIR31, MIR203A, MIR155, IL31, CLEC4C, RBM45, TCHHL1, DCD, NLRP3, SERPINB4, TSLP, ABCC11, HAVCR2, HOPX, PDCD1LG2, WLS, MARCKSL1, CARD18, DUOX1, STAT1, PRL, S100A9, CRHR1, ICAM1, HMGB1, HLA-DQA1, HLA-A, GZMB, GPT, FLT4, ERBB2, ELANE, CRH, S100A8, CLDN7, COL17A1, CHI3L1, CDA, CASP3, CASP1, CAMP, C5AR1, APOB, IFNA1, IFNA13, IFNB1, IGFBP4, RPE65, MOK, AGER, PECAM1, PDC, MTHFR, COX2, ABCC1, MMP9, MMP3, MMP2, LTA, LCN2, LAMP1, JAK2, IVL, ITGB2, IRF7, IDO1, MTCO2P12

Drugs

—

Interested in hearing about new therapies?

Lichen planus (LP) is a common inflammatory dermatosis characterized by the development of pruritic violaceous papules or plaques on mucocutaneous surfaces. Eruptions can involve the face, neck, limbs, back, genitalia, tongue, buccal mucosa, nails, and scalp. LP comprises rare variants affecting the skin and the mucosa. Rare cutaneous LP includes linear LP (referring to blaschkoid and zosteriform distributions of lichenoid lesions), actinic LP, annular LP, atrophic LP, annular atrophic LP, lichen planopilaris (comprising Graham Little-Piccardi-Lassueur syndrome and frontal fibrosing alopecia), lichen planus pigmentosus, and lichen planus pemphigoides (see these terms). Rare mucosal LP includes vulvovaginal gingival syndrome and LP sialadenitis (see these terms).